BioMarin Pharmaceutical
BMRN
₹5,071
Share price
0.15%
Change (1 day)
-27.97%
Change (1 year)
Categories
BioMarin Pharmaceutical (BMRN) - Total assets
Total assets on the balance sheet as of March 2025 : ₹622.36 Billion
According to BioMarin Pharmaceutical's latest financial reports the company's total assets are ₹622.36 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
BioMarin Pharmaceutical - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | ₹599.55 B | 5.27% |
| 2023-12-31 | ₹569.55 B | 7.96% |
| 2022-12-31 | ₹527.53 B | 18.03% |
| 2021-12-31 | ₹446.94 B | 4.5% |
| 2020-12-31 | ₹427.68 B | 27.88% |
| 2019-12-31 | ₹334.45 B | 8.04% |
| 2018-12-31 | ₹309.55 B | 4.64% |
| 2017-12-31 | ₹295.82 B | 8.19% |
| 2016-12-31 | ₹273.42 B | 10.33% |
| 2015-12-31 | ₹247.83 B | 57.97% |
| 2014-12-31 | ₹156.88 B | 13.16% |
| 2013-12-31 | ₹138.63 B | 61.45% |
| 2012-12-31 | ₹85.87 B | 24.32% |
| 2011-12-31 | ₹69.07 B | 22.08% |
| 2010-12-31 | ₹56.57 B | 32.95% |
| 2009-12-31 | ₹42.55 B | -2.35% |
| 2008-12-31 | ₹43.58 B | 36.21% |
| 2007-12-31 | ₹31.99 B | 55.88% |
| 2006-12-31 | ₹20.52 B | 133.55% |
| 2005-12-31 | ₹8.78 B | -12.89% |
| 2004-12-31 | ₹10.08 B | -13.55% |
| 2003-12-31 | ₹11.67 B | 120.02% |
| 2002-12-31 | ₹5.30 B | -36.01% |
| 2001-12-31 | ₹8.29 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Ultragenyx Pharmaceutical RARE | ₹114.24 B | -81.64% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | ₹7.50 B | -98.79% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | ₹28.21 B | -95.47% | 🇺🇸 USA |
 Sanofi SNY | ₹12.425 T | 1,896.53% | 🇫🇷 France |
 Amicus Therapeutics
FOLD | ₹68.77 B | -88.95% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | ₹79.14 B | -87.28% | 🇺🇸 USA |